vs
Side-by-side financial comparison of DYNAVAX TECHNOLOGIES CORP (DVAX) and JBG SMITH Properties (JBGS). Click either name above to swap in a different company.
JBG SMITH Properties is the larger business by last-quarter revenue ($127.6M vs $94.9M, roughly 1.3× DYNAVAX TECHNOLOGIES CORP). DYNAVAX TECHNOLOGIES CORP runs the higher net margin — 28.4% vs -35.7%, a 64.1% gap on every dollar of revenue. On growth, DYNAVAX TECHNOLOGIES CORP posted the faster year-over-year revenue change (17.7% vs -2.5%). Over the past eight quarters, DYNAVAX TECHNOLOGIES CORP's revenue compounded faster (30.6% CAGR vs -6.3%).
Dynavax Technologies Corp is a commercial-stage biopharmaceutical company specializing in the research, development, and production of innovative vaccines and immunotherapies for infectious diseases. Its lead approved product is Heplisav-B, an adult hepatitis B vaccine, with core markets in North America and Europe, alongside a pipeline of candidates addressing unmet public health needs.
JBG SMITH PropertiesJBGSEarnings & Financial Report
JBG SMITH Properties is a publicly traded real estate investment trust based in Bethesda, Maryland.
DVAX vs JBGS — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $94.9M | $127.6M |
| Net Profit | $26.9M | $-45.5M |
| Gross Margin | — | — |
| Operating Margin | 22.4% | -47.5% |
| Net Margin | 28.4% | -35.7% |
| Revenue YoY | 17.7% | -2.5% |
| Net Profit YoY | 53.0% | 24.0% |
| EPS (diluted) | $0.21 | $-0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $127.6M | ||
| Q3 25 | $94.9M | $123.9M | ||
| Q2 25 | $95.4M | $126.5M | ||
| Q1 25 | $68.2M | $120.7M | ||
| Q4 24 | $72.0M | $130.8M | ||
| Q3 24 | $80.6M | $136.0M | ||
| Q2 24 | $73.8M | $135.3M | ||
| Q1 24 | $50.8M | $145.2M |
| Q4 25 | — | $-45.5M | ||
| Q3 25 | $26.9M | $-28.6M | ||
| Q2 25 | $18.7M | $-19.2M | ||
| Q1 25 | $-96.1M | $-45.7M | ||
| Q4 24 | $7.0M | $-59.9M | ||
| Q3 24 | $17.6M | $-27.0M | ||
| Q2 24 | $11.4M | $-24.4M | ||
| Q1 24 | $-8.7M | $-32.3M |
| Q4 25 | — | -47.5% | ||
| Q3 25 | 22.4% | -27.5% | ||
| Q2 25 | 15.1% | -18.4% | ||
| Q1 25 | -34.7% | -44.7% | ||
| Q4 24 | -2.3% | -53.6% | ||
| Q3 24 | 12.5% | -22.4% | ||
| Q2 24 | 7.0% | -24.3% | ||
| Q1 24 | -35.0% | -30.1% |
| Q4 25 | — | -35.7% | ||
| Q3 25 | 28.4% | -23.1% | ||
| Q2 25 | 19.6% | -15.2% | ||
| Q1 25 | -141.0% | -37.9% | ||
| Q4 24 | 9.8% | -45.8% | ||
| Q3 24 | 21.8% | -19.8% | ||
| Q2 24 | 15.4% | -18.0% | ||
| Q1 24 | -17.2% | -22.2% |
| Q4 25 | — | $-0.76 | ||
| Q3 25 | $0.21 | $-0.48 | ||
| Q2 25 | $0.14 | $-0.29 | ||
| Q1 25 | $-0.77 | $-0.56 | ||
| Q4 24 | $0.07 | $-0.70 | ||
| Q3 24 | $0.12 | $-0.32 | ||
| Q2 24 | $0.08 | $-0.27 | ||
| Q1 24 | $-0.07 | $-0.36 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $160.2M | $75.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $534.1M | $1.2B |
| Total Assets | $946.5M | $4.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $75.3M | ||
| Q3 25 | $160.2M | $64.4M | ||
| Q2 25 | $99.1M | $61.4M | ||
| Q1 25 | $51.7M | $81.3M | ||
| Q4 24 | $95.9M | $145.8M | ||
| Q3 24 | $119.3M | $137.0M | ||
| Q2 24 | $112.5M | $163.5M | ||
| Q1 24 | $132.0M | $220.5M |
| Q4 25 | — | $1.2B | ||
| Q3 25 | $534.1M | $1.2B | ||
| Q2 25 | $494.2M | $1.3B | ||
| Q1 25 | $530.9M | $1.6B | ||
| Q4 24 | $596.8M | $1.8B | ||
| Q3 24 | $681.4M | $1.9B | ||
| Q2 24 | $642.8M | $2.0B | ||
| Q1 24 | $618.5M | $2.1B |
| Q4 25 | — | $4.4B | ||
| Q3 25 | $946.5M | $4.4B | ||
| Q2 25 | $918.4M | $4.5B | ||
| Q1 25 | $945.9M | $4.7B | ||
| Q4 24 | $986.3M | $5.0B | ||
| Q3 24 | $1.1B | $5.2B | ||
| Q2 24 | $1.0B | $5.3B | ||
| Q1 24 | $986.6M | $5.4B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $33.8M | $73.3M |
| Free Cash FlowOCF − Capex | $32.6M | — |
| FCF MarginFCF / Revenue | 34.4% | — |
| Capex IntensityCapex / Revenue | 1.3% | — |
| Cash ConversionOCF / Net Profit | 1.26× | — |
| TTM Free Cash FlowTrailing 4 quarters | $80.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $73.3M | ||
| Q3 25 | $33.8M | $8.9M | ||
| Q2 25 | $23.4M | $18.8M | ||
| Q1 25 | $-19.6M | $12.9M | ||
| Q4 24 | $53.0M | $129.4M | ||
| Q3 24 | $19.5M | $26.4M | ||
| Q2 24 | $10.7M | $23.8M | ||
| Q1 24 | $-16.7M | $37.0M |
| Q4 25 | — | — | ||
| Q3 25 | $32.6M | — | ||
| Q2 25 | $22.0M | — | ||
| Q1 25 | $-23.6M | — | ||
| Q4 24 | $49.5M | — | ||
| Q3 24 | $18.1M | — | ||
| Q2 24 | $9.9M | — | ||
| Q1 24 | $-17.4M | — |
| Q4 25 | — | — | ||
| Q3 25 | 34.4% | — | ||
| Q2 25 | 23.0% | — | ||
| Q1 25 | -34.6% | — | ||
| Q4 24 | 68.8% | — | ||
| Q3 24 | 22.5% | — | ||
| Q2 24 | 13.5% | — | ||
| Q1 24 | -34.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | 5.8% | — | ||
| Q4 24 | 4.8% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 1.1% | — | ||
| Q1 24 | 1.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.26× | — | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 7.52× | — | ||
| Q3 24 | 1.11× | — | ||
| Q2 24 | 0.94× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DVAX
| HEPLISAVB | $90.0M | 95% |
| US Department Of Defense | $4.7M | 5% |
JBGS
Segment breakdown not available.
